Skip to main content
. 2014 May 20;17(5):391–400. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2014.05.05

3.

厄洛替尼治疗114例复发性非小细胞肺癌患者血清肿瘤标志物与PFS的多因素分析

Multivariate analysis of PFS and serum tumor markers in the 114 recurrent lung cancer patients treated with Erlotinib

PFS
HR(95%CI) P
PFS: progression-free survival.
SP-D 1.865 (1.14-3.04) 0.013
TGF-α 0.929 (0.56-1.55) 0.780
MMP-9 1.357 (0.85-2.18) 0.206
KL-6 1.253 (0.77-2.03) 0.359
TPS 1.698 (1.03-2.79) 0.037